New report: Anticoagulant Reversal Drugs Market opportunities and forecast assessment, 2020 to 2027

Publisher: The Insight Partners

According to our new market research study on “Anticoagulant Reversal Drugs Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product, and Distribution channel,” the market is expected to reach US$ 2,276.54 million in 2027 from US$ 922.55 in 2019; it is estimated to grow at a CAGR of 12.6% from 2020 to 2027. The report highlights trends prevailing in the global anticoagulant reversal drugs market, and the factors governing the market growth.

Based on distribution channel, the anticoagulant reversal drugs market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2019, and is estimated to register the highest CAGR in the market during the forecast period. Hospital pharmacies offer complex and specialized medicines, which may not be available in a retail pharmacy. It ensures the availability of right medication, in the right dose and at the right time. These factors are expected to contribute to the growth of the market during the forecast period.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.theinsightpartners.com/sample/TIPRE00004954/

The global anticoagulant reversal drugs market growth is mainly attributed to the rising prevalence of atrial fibrillation (AFib) and stroke. However, the high cost of anticoagulant reversal drugs is restricting the market growth.

Boehringer Ingelheim International GmbH; Pfizer Inc; Octapharma AG; Amag Pharmaceuticals, Inc; Fresenius Kabi AG; Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals); CSL Limited; China Biologic Products, Inc; Grifols, S.A; and Shanghai RAAS Blood Products Co., Ltd are among the key companies in the anticoagulant reversal drugs market.  

Anticoagulant Reversal Drugs Market – by Product

• Prothrombin Complex Concentrates
• Vitamin K
• Protamine
• Tranexamic Acid
• Idarucizumab
• AndeXXa

Anticoagulant Reversal Drugs Market – by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Others

Anticoagulant Reversal Drugs Market – by Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA
• South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America

Company Profiles

• Boehringer Ingelheim International GmbH
• Pfizer Inc
• Octapharma AG
• Amag Pharmaceuticals, Inc
• Fresenius Kabi AG
• Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
• CSL Limited
• China Biologic Products, Inc
• Grifols, S.A
• Shanghai RAAS Blood Products Co., Ltd.

Purchase a copy of this research report @ https://www.theinsightpartners.com/buy/TIPRE00004954/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com